Trial intelligence / Profile preview

Vitamin K2 in Parkinson’s Disease with mitochondrial dysfunction

DRKS00019932Phase 2Not yet recruiting

Sponsor
Universitätsklinikum Schleswig-Holstein
Start
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Vitamin K2 (MK-7) with Placebo (2 arms). Planned start Dec 2019; status: not yet recruiting.

02

Drugs

menaquinone
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on DRKS00019932.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00019932.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call